The burden of healthcare costs associated with prostate cancer in Ireland

The burden of healthcare costs associated with prostate cancer in Ireland

<h4>Purpose</h4> <p>With one of the highest incidence rates across Europe and the rest of the World in 2012, the Republic of Ireland (RoI) has experienced significant increases in prostate cancer (PCa) incidence since 1994. The main driver is the widespread use of PSA testing whic...

Full description

Bibliographic Details
Main Authors:	Burns, R, Leal, J, Wolstenholme, J, O’Neill, C, Sullivan, F, Drummond, F, Sharp, L
Format:	Journal article
Published:	Wichtig Publishing 2016

Similar Items

Estimating age and ethnic variation in the histological prevalence of prostate cancer to inform the impact of screening policies.
by: Leal, J, et al.
Published: (2014)

Estimating age and ethnic variation in the histological prevalence of prostate cancer to inform the impact of screening policies
by: Leal, J, et al.
Published: (2014)

Economic burden of cancer across the European Union: A population-based cost analysis
by: Luengo-Fernandez, R, et al.
Published: (2013)

Economic burden of cancer across the European Union: a population-based cost analysis.
by: Luengo-Fernandez, R, et al.
Published: (2013)

Economic burden of malignant blood disorders across Europe: A population-based cost analysis
by: Burns, R, et al.
Published: (2016)

Economic burden of bladder cancer across the European Union
by: Leal, J, et al.
Published: (2015)

Economic burden of non-malignant blood disorders across Europe: A population-based cost study
by: Luengo-Fernandez, R, et al.
Published: (2016)

Burden of disease and costs of aneurysmal subarachnoid haemorrhage (aSAH) in the United Kingdom.
by: Rivero-Arias, O, et al.
Published: (2010)

Economic burden of dementia and healthcare costs of demented elderly in Malaysia
by: Koris, Roshanim
Published: (2018)

Effectiveness and cost-effectiveness of prognostic markers in prostate cancer.
by: Calvert, N, et al.
Published: (2003)

The economic burden of cancer, coronary heart disease, dementia and stroke in England in 2018: an evaluation of two cohort studies
by: Landeiro, F, et al.
Published: (2024)

Shared burden: the association between cancer diagnosis, financial toxicity, and healthcare cost-related coping mechanisms by family members of non-elderly patients in the USA
by: Kazzi, Bahaa, et al.
Published: (2022)

Estimating the sensitivity of a prostate cancer screening programme for different PSA cut-off levels: A UK case study
by: Leal, J, et al.
Published: (2018)

Lead time associated with screening for prostate cancer.
by: Törnblom, M, et al.
Published: (2004)

Estimating comparable English healthcare costs for multiple diseases and unrelated future costs for use in health and public health economic modelling
by: Briggs, A, et al.
Published: (2018)

Association of diabetes mellitus with prostate cancer: nested case-control study (Prostate testing for cancer and treatment study).
by: Turner, E, et al.
Published: (2011)

Prostate cancer screening in the workplace. Employer costs.
by: Snyder, C, et al.
Published: (1998)

Association of reported prostate cancer risk alleles with PSA levels among men without a diagnosis of prostate cancer.
by: Wiklund, F, et al.
Published: (2009)

Economic burden of CVD across the European Union: trends over the last decade
by: Leal, J, et al.
Published: (2017)

Economic burden of stroke across Europe: a population-based cost analysis
by: Luengo-Fernandez, R, et al.
Published: (2019)

Bone: The growing cost of fractures in Ireland
by: Edwards, M, et al.
Published: (2012)

Who makes the decision? Malaysian healthcare professionals' views on prostate cancer treatment
by: Lee, Yew Kong, et al.
Published: (2014)

Directory of British Associations & Associations in Ireland /
by: Henderson, G. P., et al.
Published: (1992)

Directory of British associations and associations in Ireland /
Published: (1986)

Healthcare and wider societal implications of stillbirth: a population-based cost of illness study
by: Campbell, H, et al.
Published: (2017)

Staging in prostate cancer.
by: Wilkinson, B, et al.
Published: (2002)

Cancer burden in Africa and opportunities for prevention
by: Jemal, A, et al.
Published: (2012)

Changes in circulating microRNA levels associated with prostate cancer.
by: Bryant, R, et al.
Published: (2012)

Circulating microRNAs are associated with the development and progression of prostate cancer
by: Bryant, R, et al.
Published: (2012)

Economic burden of cardiovascular diseases in the European Union: a population-based cost study
by: Luengo-Fernandez, R, et al.
Published: (2023)

Optimal healthcare decision making under multiple mathematical models: application in prostate cancer screening
by: Trikalinos, Thomas, et al.
Published: (2018)

Five genetic variants associated with prostate cancer.
by: Vickers, A, et al.
Published: (2008)

Susceptibility loci associated with prostate cancer progression and mortality.
by: Gallagher, D, et al.
Published: (2010)

Prostate cancer: screening approaches.
by: Donovan, J, et al.
Published: (2005)

Prostate cancer: screening approaches
by: Donovan, J, et al.
Published: (2005)

Multiple newly identified loci associated with prostate cancer susceptibility.
by: Eeles, R, et al.
Published: (2008)

Inequalities in the access, offer and uptake of antenatal screening in Northern Ireland
by: Alderdice, F, et al.
Published: (2009)

Systematic review and meta-analysis of the associations between body mass index, prostate cancer, advanced prostate cancer, and prostate-specific antigen
by: Harrison, S, et al.
Published: (2020)

Impact of variation in Type 2 diabetes care on health outcomes and healthcare costs
by: Keng, M, et al.
Published: (2019)

UK research expenditure on dementia, heart disease, stroke and cancer: Are levels of spending related to disease burden?
by: Luengo-Fernandez, R, et al.
Published: (2012)